A remarkable bit of data emerged from last week’s Center for Rural Pennsylvania hearing, the 20th event looking specifically at illegal drugs, addiction and recovery: Pennsylvania’s mental health and ...
Iris Bincovich, CEO of Innocan Pharma, will be presenting at 2PM ET at the Lotus Suite West on October 30th. Members of the Innocan Pharma management will also be holding one-on-one investor meetings ...
The NDA submission for the treatment of presbyopia is supported by the positive data results from the pivotal Phase 3 CLARITY study. Aceclidine is a new chemical entity in the United States and is not ...